The lymphocyte phenotype in patients with primary fibromyalgia

Upsala Journal of Medical Sciences

Volumn 101, Issue 3, 1996, Pages 251-256

  Samborski, W ^a   Lacki, J K ^a   Wiktorowicz, K E ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; FEMALE; FIBROMYALGIA; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ADULT; AGED; ANTIGENS, CD; FEMALE; FIBROMYALGIA; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LYMPHOCYTES; MALE; MIDDLE AGED; PHENOTYPE;

EID: 0030347477     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009739609178924     Document Type: Article

References (35)

1. Bengtsson, A., Ernerudh, J., Vrethem, M. & Skogh, T.: Absence of autoantibodies in primary fibromyalgia. J Rheumatol 17:1682-1683, 1990.
2. Bennett, R.M., Clark, S.R., Campbell, S.M. & Burckhardt, C.S.: Low levels of somatomedin C in patients with the fibromyalgia syndrome. Arthritis Rheum 35:1113-1116, 1992.
3. Berg, P.A. & Klein, R.: Fibromyalgie-Syndrom. Eine neuroendokrinolo-gische Autoimmunerkrankung? Dtsch med Wschr 119:429-435, 1994.
4. Calco, C.F., Chavanel, G. & Senik, A.: Substance P enhances I1-2 expression in activated human T cells. J Immunol 148:3498-3504, 1992.
5. Caro, X.: Immunofluorescent detectionof IgG at dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis Rheum 27:1174-1178, 1984.
6. Cleveland, C.H., Fisher, R.H., Brestel, E.P., Esinhart, J.D. & Metzger, W.J.: Chronic rhinitis: an underrecognized association with fibromyalgia. Allergy Proc 13:263-267, 1992.
7. Crofford, L.J.: Neuroendocrine aspects of fibromyalgia. J of Musculoskeletal Pain 3:125-133, 1994.
8. Eide, P.K. & Hole, K.: Interactions between serotonin and substance P in the spinal regulation of nociception. Brain Res 564:33-39, 1991.
9. Elam, M., Johansson, G. & Wallin, B.G.: Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48:371-375, 1992.
10. Ferraccioli, G., Cavalieri, F., Salaffi, F., Fontana S., Scita, F., Nolli, M. & Maestri, D.: Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol 17:869-873, 1990.
11. Fischer, A.A.: Pressure threshold measurement of diagnosis of myofascial pain and evaluation of treatment results. Clin J Pain 2:207-214, 1987.
12. Goldenberg, D.L.: Fibromyalgia syndrome. An emerging but controversial condition. JAMA 257:2782-2787, 1987.
13. Hader, N., Rimon, D., Kinarty, A. & Lahat, N.: Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome. Arthritis Rheum 34:866-872, 1991.
14. Jessop, D.S., Chowdrey, H.S., Larsen, P.J. & Lightman, S.L.: Substance P: Multifunctional eptide in the hypothalamo-pituitary system? J Endocrinol 132:331-337, 1992.
15. Klein, R., Bänsch, M. & Berg, P.: Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendo-crinology 17:593-598, 1992.
16. McCain, G.A. & Tilbe, K.S.: Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis. J Rheumatol (suppl 19) 16:154-157, 1989.
17. Meske-Brand, S., Kapp, A, & Müller, W.: Die generalisierte Tendomyopathie, ein syndrom im rahmen der atopie? Akt Rheumatol 9:156-158, 1984.
18. Murphy, R.M. & Zemlan, F.P.: Differential effects of substance P on serotonin modulated spinal nociceptive reflexes. Psychopharmacology (Berlin) 93:118-121, 1987.
19. Peter, J.B. & Wallace, D.J.: Abnormal immune regulation in fibromyalgia. Arthritis Rheum 31:24, 1988.
20. Rameshwar, P., Gascon, P. & Ganea, D.: Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance P. J Neuroimmunol 37:65-74, 1992.
21. Russell, I.J.: Biochemical abnormalities in fibromyalgia syndrome. J Muskuloskeletal Pain 2:101-115, 1994.
22. Russell, I.J., Michalek, J.E. & Vipraio, G.A. et al: Serum serotonin and platelet 3H-imipramine binding receptor density in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104-109, 1992.
23. Russell, I.J., Michalek, J.E., Vipraio, G.A., Fletcher, E.M. & Wall, K.: Serum aminoacids in fibrositis/fibromyalgia syndrome. J Rheumatol 19:158-163, 1989.
24. Russell, I.J., Orr, M.D., Littman, B., Vipraio, G.A., Alboukrek, D., Michalek. J.E., Lopez, Y. & McKillip, F.: Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 37:1593-1601, 1994.
25. Russell, I.J., Vaeroy, H., Javors, M. & Nyberg, F.: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35:550-556, 1992.
26. Russell, I.J., Vipraio, G.A., Craig, F.E., King, D.E. & Monteil, M.M.: False CD 19 positive-CD5 cells in fibromyalgia. Arthritis Rheum 37 (suppl):350, 1994.
27. Russell, I.J., Vipraio, G.A. & Lopez, Y.M.: Serum serotonin in fibromyalgia syndrome, rheumatoid arthritis, osteoarthritis and healthy normal controls. Arthritis Rheum 36:223, 1993.
28. Russell, I.J., Vipraio, G.A., Tovar, Z., Michalek, J. & Fletcher, E.: Abnormal natural killer cell activity in fibrositis syndrome in responsive in vitro to I1-2. Arthritis Rheum 31:24, 1988.
29. Samborski, W., Pawlik, I., Konys, J. & Mackiewicz. U.: The assesments of atopia symptoms in fibromyalgia patients. Reumatologia 4:45-52, 1994.
30. Samborski, W., Stratz. T., Kretzman, W., Mennet, P. & Muller. W.: Vergleichende undersuchugen uber das vorkommen vegetativer und funktioneller beschwerden bei lumbalgien und generalisierten tendomyopathien (fibromyalgia). Z Rheumatol 50:378-381. 1991.
31. Samborski, W., Stratz, T., Kretzman, W., Mennet, P. & Muller, W.: The comparison of incidence of vegetative and functional symptoms in patients with fibromyalgia and chronic low back pain syndrome. Scand J Rheumatol 94 (suppl): 16. 1992.
32. Stratz, T., Samborski, W., Hrycaj, P., Pap, T., Mackiewicz, S., Mennet, P. & Müller, W., Die serotoninkonzentration im serum bei patienten mit generalisierter tendomyopathie (fibromyalgie) und chronischer polyarthritis. Med Klin 88:458-462, 1993.
33. Vaeroy, H., Helle, R., Forre, O., Kass, E. & Terenius, L.: Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 32:21-26, 1988.
34. Wolfe, F., Smythe, H.A. & Yunus, M.B. et al.: The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33:160-172, 1990.
35. Yunus, M.B., Dailey, J.C. & Aldag, J C. et al., Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 19:90-94, 1992.